HCV-Induced Hepatocellular Carcinoma
"Risk Factors for Development of Hepatocellular Carcinoma among Australians with Hepatitis C: A Case-Control Study."
Published in Hepatitis Weekly, August 16th, 1999
According to the authors' abstract of an article published in Australian and New Zealand Journal of Medicine, "Background: Older patients with cirrhosis due to hepatitis C are at risk of developing hepatocellular carcinoma (HCC), but additional risk factors may vary between countries. Aim: In the present study, we sought to identify additional risk factors for HCC among a cohort of Australian patients with chronic hepatitis C. Methods: Case-control study of patients with advanced fibrosis stage hepatitis C who developed HCC during five-year follow up at a referral liver clinic. Cases were compared to twice the number of age-matched patients with chronic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1999-08-16)
More Articles from Hepatitis Weekly
- Therapy
IFN Useful in HCV Patients with Cirrhosis - Disease Markers
Portal Lymphadenopathy Suggests Liver Damage in HCV+ - Genomics
Cyclin D1 Gene Plays Role in Hepatitis-Related Cancer - Research & Development
NIH Announces 8-Year Hepatitis Therapy Study - Risk Factors
IFN Therapy Reduces Liver Cancer in HCV Patients - Therapy
Prior Mood/Anxiety Problems Don't Preclude IFN Treatment - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
